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Abstract
Gulf War Illness (GWI) is a multi-symptom disorder with features characteristic of persistent 
sickness behavior. Among conditions encountered in the Gulf War (GW) theater were 
physiological stressors (e.g., heat/cold/physical activity/sleep deprivation), prophylactic treatment 
with the reversible AChE inhibitor, pyridostigmine bromide (PB), the insect repellent, N, N-
diethyl-meta-toluamide (DEET), and potentially the nerve agent, sarin. Prior exposure to the anti-
inflammatory glucocorticoid, corticosterone (CORT), at levels associated with high physiological 
stress, can paradoxically prime the CNS to produce a robust proinflammatory response to 
neurotoxicants and systemic inflammation; such neuroinflammatory effects can be associated with 
sickness behavior. Here, we examined whether CORT primed the CNS to mount 
neuroinflammatory responses to GW exposures as a potential model of GWI. Male C57BL/6 mice 
were treated with chronic (14 days) PB/DEET, subchronic (7–14 days) CORT, and acute exposure 
(day 15) to diisopropyl fluorophosphate (DFP), a sarin surrogate and irreversible AChE inhibitor. 
DFP alone caused marked brain-wide neuroinflammation assessed by qPCR of tumor necrosis 
factor-α, IL6, chemokine (C-C motif) ligand 2, IL-1β, leukemia inhibitory factor, and oncostatin 
M. Pre-treatment with high physiological levels of CORT greatly augmented (up to 300-fold) the 
neuroinflammatory responses to DFP. Anti-inflammatory pre-treatment with minocycline 
suppressed many proinflammatory responses to CORT+DFP. Our findings are suggestive of a 
possible critical, yet unrecognized interaction between the stressor/environment of the GW theater 
and agent exposure(s) unique to this war. Such exposures may in fact prime the CNS to amplify 
future neuroinflammatory responses to pathogens, injury, or toxicity. Such occurrences could 
potentially result in the prolonged episodes of sickness behavior observed in GWI.
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Gulf War Illness (GWI) is a multi-symptom disorder with features resembling ‘sickness’ 
behavior (Dantzer and Kelley 2007; Dantzer et al. 2008), for example, cognitive 
impairment, fatigue, depression, sleep disruption, muscle and joint pain, and gastrointestinal 
and dermatological problems (Fukuda et al. 1998; Steele 2000; Haley et al. 2001; Golomb 
2008). Typically, sickness behavior accompanies an inflammatory response to infection or 
injury and resolves over time with gradual restoration of homeostasis (Pavlov et al. 2003). 
However, in GWI the symptoms persist, findings indicative of a heightened or chronic 
neuroimmune/neuroinflammatory reaction for which the etiology remains unknown.
Enhanced expression of proinflammatory cytokines and chemokines serves as the basis for 
normal and pathophysiological inflammation states, including sickness behavior (Dantzer 
and Kelley 2007). Microglia and astrocytes, major subtypes of CNS glia, are thought to be 
the primary sources and targets of cytokines and chemokines that play a role in brain 
neuroinflammatory responses (Block and Hong 2005; Block et al. 2007; Sriram and 
O’Callaghan 2007; O’Callaghan et al. 2014). These glial cells also are speculated to play a 
key role in pain (Narita et al. 2008; Schreiber et al. 2008), depression (Miller and 
O’Callaghan 2005; Dantzer et al. 2008), and sickness behavior (Dantzer et al. 2008; 
Biesmans et al. 2013; Hines et al. 2013). Together, these observations lead us to hypothesize 
that conditions and exposures that result in exacerbated or chronic expression of 
proinflammatory mediators in the CNS may play a role in the symptoms exhibited by 
veterans suffering from GWI.
Several conditions and exposures have been hypothesized to serve as instigating events that 
precipitated the recurring/chronic symptoms associated with GWI (Federal Research 
Advisory Committee on Gulf War Veterans Illnesses’ (RAC) Report 2008, 2014). Chief 
among these events are acute nerve agent exposures resulting from detonations at 
Khamisiyah and other Iraqi weapons facilities (RAC Reports 2008, 2014), prophylactic 
treatment with the reversible acetylcholinesterase (AChE) inhibitor pyridostigmine bromide 
(PB), and continuous exposure to pesticides/insect repellants in theater (RAC Reports 2008, 
2014). Inhibition of AChE because of sarin and PB exposures has been put forth as a basis 
for the symptoms of GWI (Golomb 2008) and, at least with respect to sarin, such exposures 
can produce neuroinflammation in a rat model (Spradling et al. 2011). Whether exposure to 
the reversible AChE inhibitor, PB, or insecticides and insect repellants, like N,N-diethyl-
meta-toluamide (DEET) can be neuroinflammatory alone, or when combined with sarin 
exposure, remains to be examined. Physiological stress experienced in theater also has been 
proposed as a potential contributor to GWI (Sapolsky 1998). Consistent with this view, we 
have observed that prior subchronic exposure to the rodent stress hormone corticosterone 
(CORT) can enhance the neuroinflammation associated with neurotoxicity (Kelly et al. 
2012). Here, we show that the sarin surrogate diisopropyl fluorophosphate (DFP), results in 
neuroinflammation in the mouse brain, an effect markedly enhanced by prior exposure to 
CORT. These findings suggest that combined exposures to CORT and DFP may serve as an 
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animal model of the pathobiology of GWI. Importantly, anti-inflammatory therapy with 
minocycline (MINO) suppressed many of the neuroinflammatory effects observed in this 




The following drugs and chemicals were kindly provided by or obtained from the sources 
indicated: DFP, (Sigma, St. Louis, MO, USA), PB (Sigma), DEET (Sigma), CORT 
(Steraloids, Inc., Newport, RI, USA), MINO (Sigma), bicinchoninic acid protein assay 
reagent, and bovine serum albumin (Pierce Chemical Co., Rockford, IL, USA). The 
materials used in the glial fibrillary acidic protein (GFAP) assay previously have been 
described in detail (O’Callaghan 1991, 2002). All other reagents were of at least analytical 
grade and obtained from a variety of commercial sources.
Animals
Adult male C57Bl/6J mice (n = 5 mice per group) were purchased from Jackson Laboratory 
(Bar Harbor, ME, USA). All procedures were performed under protocols approved by the 
Institutional Animal Care and Use Committee of the Centers for Disease Control and 
Prevention, National Institute for Occupational Safety and Health, and the animal facility 
was certified by the American Association for Accreditation of Laboratory Animal Care. 
Upon receipt, the mice were housed individually in a temperature (21 ± 1°C) and humidity-
controlled (50 ± 10%) colony room maintained under filtered positive-pressure ventilation 
on a 12 h light/12 h dark cycle beginning at 06:00 hours. The plastic tub cages were 46 × 25 
× 15 cm; cage bedding consisted of heat-treated pine shavings spread at a depth of 
approximately 4 cm. Purina rat/mouse chow and water were available ad libitum.
Dosing
The dosing paradigm is presented in Fig. 1. Mice were dosed once per day for 14 days with 
PB (2 mg/kg/day, s.c.) and DEET (30 mg/kg/day, s.c). On days 8–15, mice received CORT 
in the drinking water (200 mg/L in 1.2% ethanol, EtOH). This CORT regimen is known to 
be immunosuppressive as evidenced by decreased thymus weight (e.g., see O’Callaghan et 
al. 1991); thymus and spleen weights were confirmed to be decreased (> 20%) in all CORT 
(including PB/DEET+CORT) groups in this study. Control groups received saline injections 
and the 1.2% EtOH/water vehicle in the same paradigm and were controlled for the potential 
of handling stress. Finally, on day 15 mice were treated with a single injection of either DFP 
(4 mg/kg, i.p.) or saline (0.9%) (Fig. 1a). DFP causes behavioral seizures that abate over 
hours; DFP-induced seizure activity was not affected by PB/DEET pre-treatments and PB/
DEET alone did not cause seizures. To compare the effects of handling, there was a non-
handled control group which did not receive 14 days of saline injections. However, there 
were no significant effects of handling for our outcome measures; therefore, the non-handled 
group was not included in our final data analyses. For the MINO experiment, mice were 
dosed with MINO (100 mg/kg, s.c.) once per day for 15 days. On days 8–15 mice received 
CORT in the drinking water (200 mg/L in 1.2% EtOH). Control groups received saline 
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injections and the 1.2% EtOH/water vehicle in the same paradigm. On day 15, mice were 
treated with a single injection of DFP (4 mg/kg, i.p.) or saline (0.9%) (Fig. 1b).
Brain dissection and tissue preparation
Mice were killed by decapitation and the brains rapidly removed. Frontal cortex (FC), 
hippocampus (HIP), striatum (STR), hypothalamus (HYPO), olfactory bulbs (OB), and 
cerebellum (CB) were dissected free-hand on a thermoelectric cold platform (Model TCP-2; 
Aldrich Chemical Co., Milwaukee, WI, USA). Brain regions from one hemisphere were 
frozen at −80°C and used for subsequent isolation of total RNA; brain regions from the 
other hemisphere were used for total and specific protein analyses. These regions were 
weighed, homogenized with an ultrasonic probe (model XL-2005; Heat Systems, 
Farmingdale, NY, USA) in 10 volumes of hot (90–95°C) 1% sodium dodecyl sulfate, and 
stored at −70°C for further analysis.
RNA isolation, cDNA synthesis, and qPCR
Total RNA was isolated at 2, 6, and 12 h after DFP using methods previously described 
(Kelly et al. 2012). Briefly, total RNA was isolated using Trizol® reagent (Invitrogen, Grand 
Island, NY, USA) and Phase-lock heavy gel (Eppendorf AG, Hamburg, Germany) and 
purification by RNeasy mini-spin column (Qiagen, Valencia, CA, USA). Reverse 
transcription of the total RNA (1 μg) to cDNA was achieved by SuperScript™ II RNase H− 
and oligo (dT)12–18 primers (Invitrogen) in a 20 μL reaction. qPCR analysis of 
glyceraldehyde-3-phosphate dehydrogenase, tumor necrosis factor alpha (TNF-α), 
interleukin 6 (IL6), chemokine (C-C motif) ligand 2 (CCL2), interleukin 1beta (IL-1β), 
leukemia inhibitory factor (LIF), and oncostatin M (OSM) was performed in an ABI PRISM 
7500 sequence detection system (Applied Biosystems, Carlsbad, CA, USA) in combination 
with TaqMan® chemistry. Relative quantification of gene expression was performed using 
the comparative threshold (CT) method (Livak and Schmittgen 2001; Schmittgen and Livak 
2008). Changes in mRNA expression levels were calculated after normalization to 
glyceraldehyde-3-phosphate dehydrogenase. The ratios obtained after normalization are 
expressed as fold changes over corresponding controls.
GFAP immunoassay
GFAP protein was assayed at 72 h post DFP exposure as previously described (O’Callaghan 
1991, 2002). In brief, a rabbit polyclonal antibody to GFAP was coated on the wells of 
Immulon 2 flat bottom microtiter plates (Thermo Labsystems, Franklin, MA, USA). The 
sodium dodecyl sulfate homogenates and standards were diluted in phosphate-buffered 
saline (PBS) (pH 7.4) containing 0.5% Triton X-100. After blocking non-specific binding 
with 5% non-fat dry milk, aliquots of homogenate and standards were added to the wells and 
incubated for 1 h at 23°C. Following washes, a mouse monoclonal antibody to GFAP (1 : 
400; DAKO, Carpinteria, CA, USA) was added to ‘sandwich’ the protein between the two 
antibodies. An alkaline phosphatase-conjugated antibody directed against mouse IgG was 
then added and a colored reaction product was obtained by subsequent addition of the 
enzyme substrate p-nitrophenol. Quantification by spectrophotometry of the colored reaction 
product at 405 nm was performed on a microplate reader (Spectra Max Plus) and analyzed 
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using Soft Max Pro Plus software (Molecular Devices, Sunnyvale, CA, USA). The amount 
of GFAP in the samples was calculated as μg GFAP per mg total protein. Total protein was 
determined by the bicinchoninic acid method (Smith et al. 1985) using bovine serum 
albumin as a standard.
Glial immunohistochemistry and neurodegeneration staining
Mice were anesthetized with Sleep Away® (0.1 mL; Fort Dodge Animal Health, Fort 
Dodge, IA, USA) and transcardially perfused with saline (0.9%) followed by 4% 
paraformaldehyde in 0.1 M PBS 24 h post DFP injection. Brains were removed and stored in 
4% paraformaldehyde in 0.1 M PBS to be sent to FD Neurotechnologies (Columbia, MD, 
USA) for subsequent processing and staining for GFAP and ionized calcium-binding adapter 
molecule 1 (Iba1) (markers for activation of astrocytes and microglia, respectively), as well 
as FD NeuroSilver™ and Fluoro-Jade B (markers for neuronal degeneration). The sections 
were visualized using an Olympus AX70 microscope (Olympus, Pittsburgh, PA, USA) with 
an UPlanFl 4× 0.13 numerical aperture (GFAP, Iba1, and Fluoro-Jade B) or 10× 0.30 
numerical aperture (FD Neurosilver™) objective lens and images captured using Cell Sens 
Dimension software with the Olympus DP73 digital camera (Olympus, Pittsburgh, PA, 
USA) attached to the microscope. Post-processing included cropping images to isolate the 
HIP.
Statistics
All data analyses were performed using SPSS (version 22) software (IBM, Armonk, NY, 
USA). The tests of significance were performed on log transformed data using Student’s t-
tests, one-, or two- way ANOVAS. Fisher LSD test was used as a post hoc test for appropriate 
analyses. The type of statistical test is specified in each figure legend. Values were 
considered statistically significant at a 5% level of significance (p < 0.05). Graphical 
representations are untransformed mean ± SEM.
Results
DFP causes neuroinflammation in multiple brain regions
Administration of the sarin surrogate DFP caused a brain-wide neuroinflammatory response 
(FC, HIP, STR, HYPO, OB, CB). The expression of multiple cytokine and chemokine 
mRNA was enhanced in multiple brain areas after a single dose of DFP (Fig. 2). Not all 
areas were affected equally, but all brain areas sampled showed various degrees of enhanced 
expression of multiple proinflammatory mediators. Increased expression of TNF-α, IL6, 
CCL2, IL-1β, LIF, and OSM mRNA was seen at 2 h post DFP, was increased further in 
most cases by 6 h, with a reduction toward control levels by 12 h post DFP (Fig. 3). These 
data are in general agreement with the effects noted for administration of sarin to the rat 
(Spradling et al. 2011) and together stand in contrast to the known anti-inflammatory 
responses expected for enhanced cholinergic agonism (Pavlov et al. 2003).
CORT enhances DFP neuroinflammation in multiple brain regions
Many physiological stressors, for example, high and low ambient temperatures, threats of 
danger, physical exercise, were encountered in theater during the 1991 GW and may have 
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contributed to the development of GWI (Sapolsky 1998). To emulate this possibility in our 
mouse model, we administered the stress hormone, CORT, in the drinking water for 7 days 
prior to administration of DFP. While an anti-inflammatory effect might be expected with a 
classic anti-inflammatory glucocorticoid, we found a marked exacerbation of the 
neuroinflammatory effect of DFP in all brain areas examined (Fig. 4). Again, as with DFP 
alone, the degree of the CORT-enhanced neuroinflammation varied by brain region and by 
cytokine/chemokine, but was observed in all areas sampled. Similar to the time course seen 
for DFP alone, CORT+DFP exposure resulted in a minimal neuroinflammatory response at 
2 h post DFP dosing. At the 6 h time point, mRNA expression increased and then returned to 
control levels at 12 h in both the FC and HIP (Fig. 5). The potential for experimenter 
handling to be a stressor was assessed with a non-handled control group. Handling was 
found not to be a factor in any of the group values for DFP with or without CORT or with 
other pre-treatments (data not shown). It is noteworthy that exposure to DFP alone produced 
a 14% mortality rate, whereas exposure to CORT+DFP yielded a much lower mortality rate 
(4%).
PB/DEET combination does not enhance DFP-induced neuroinflammation with or without 
prior CORT
Among the many potential exposures encountered by troops deployed to the 1991 GW were 
the prophylactic administration of PB to counteract nerve agent exposure and constant 
exposure to DEET to repel insects. Therefore, we administered both of these compounds for 
2 weeks prior to acute exposure to DFP, and evaluated the subsequent proinflammatory 
response with and without prior administration of CORT. Across multiple brain regions and 
neuroinflammatory endpoints, PB/DEET alone did not produce a neuroinflammatory 
response. Furthermore, PB/DEET treatment did not enhance DFP-induced expression of 
proinflammatory cytokines and chemokines. Instead, for most proinflammatory mediators 
prior treatment with PB/DEET slightly suppressed the DFP-related neuroinflammation at 
both 2 (data not shown) and 6 h post DFP dosing time point (Fig. 6). Exposure to CORT 
during the pre-treatment with PB/DEET negated the slight protection PB/DEET had on 
DFP-related neuroinflammation (Fig. 7). The enhancement of DFP-induced 
neuroinflammation by prior exposure to CORT was largely unaffected by the 2-week 
exposure to PB/DEET (Fig. 7).
DFP with and without CORT+PB/DEET does not cause remarkable neurodegeneration or 
gliosis
Given the marked neuroinflammation observed with DFP, as well as the further 
exacerbation by CORT, we evaluated whether these effects were associated with 
neurodegeneration, astrogliosis, or microglial activation in the FC, HIP, STR, and HYPO. 
Representative images of the HIP are shown in Fig. 8. There was no evidence of 
neurodegeneration by sensitive FD Neurosilver™ staining in any brain region evaluated. 
One exception may be minor argyrophilic neurons in the dentate gyrus of the HIP (Fig. 8a); 
however, these changes are still not considered to be noteworthy. Fluoro-Jade B staining 
also was unremarkable in all regions in all treatment groups (Fig. 8b). Astrogliosis, as 
assessed by immunostaining of GFAP, also was not observed in any brain regions, again 
with the possible exception of a minor increase in GFAP immunostaining in the CA1 region 
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of the HIP (Fig. 8c). When we assayed GFAP content across multiple brain regions by 
ELISA, no treatment-related effects were observed (Fig. 9). Minor decreases in astrogliosis 
were observed in PB/DEET+DFP groups with and without CORT in the STR. Microglia 
activation based on Iba1 staining also did not reveal an activation of this cell type across the 
brain. Minor increases in microglial activation were seen in the CA1 region of the HIP in 
PB/DEET+DFP and CORT+DFP groups (Fig. 8d). Together these data are indicative of an 
absence of neurodegeneration and glial activation after DFP with and without prior 
administration of CORT and/or PB/DEET.
Minocycline pre-treatment suppresses neuroinflammation resulting from CORT+DFP
MINO is a tetracycline class antibiotic with anti-inflammatory properties. Previously, we 
showed that the neuroinflammatory response to 1-methyl-4- phenyl-1,2,3,6-
tetrahydropyridine (MPTP) and methamphetamine could be suppressed by prior treatment 
with MINO (Sriram et al. 2006). This raised the possibility that MINO could diminish the 
neuroinflammatory response to DFP with or without prior treatment with CORT. In both FC 
and HIP, MINO pre-treatment for 2 weeks suppressed some of the neuroinflammatory 
responses to CORT+DFP (TNF-α, IL6, CCL2, IL-1β, LIF, and OSM) with the drug 
exhibiting more effectiveness in the HIP than the FC (Fig. 10).
Discussion
As many as 250,000 veterans of the 1990–1991 GW suffer from a chronic multi-symptom 
illness that resembles various aspects of sickness behavior, that is, symptoms that include 
fatigue, pain, memory problems, and GI disturbances. The etiology of GWI remains 
unknown but a variety of exposures in theater have been implicated including insect 
repellants, pesticides, the nerve agent sarin, and PB, the nerve agent antagonist widely self-
administered during the War (RAC Reports 2008, 2014). The development of an animal 
model to mirror some of these exposures and their effects related to sickness behavior would 
provide a means to better define GWI etiology and provide the basis for further research on 
effective treatments for this disorder.
Here, we demonstrate that administration of DFP, as a sarin surrogate, results in a brain-
wide neuroinflammatory response affecting multiple cytokines and chemokines, effects 
known to underlie sickness behavior in animal models (Kelley et al. 2003; Dantzer et al. 
2008; Henry et al. 2008; Huang et al. 2008). Pre-treatment with CORT as a high 
physiological stress mimic greatly exaggerated the neuroinflammatory response to DFP 
alone. Combined pre-treatment with PB and DEET, two other potential GW-relevant 
exposures, did not exacerbate neuroinflammatory responses following exposure to CORT 
and/or DFP, and in fact, had some suppressive effects on cytokine and chemokine responses.
While neuroinflammation can accompany or contribute to neural degeneration, it also can 
occur in the absence of damage (O’Callaghan et al. 2014) as a normal or exaggerated 
component of the acute phase response to an immune system insult (Godbout et al. 2005; 
Maes et al. 2007; Maes 2009; Wager-Smith and Markou 2011). These neuroinflammatory 
responses can be manifested chronically as episodic sickness behavior, symptoms consistent 
with GWI. When we administered DFP to mimic the nerve agent exposures encountered in 
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the GW theater, there were brain region ‘hot spots’ for a given cytokine/chemokine, but no 
clear pattern emerged that might provide insights for the basis of these effects. Indeed, it was 
surprising that DFP was proinflammatory as overwhelming enhancement of cholinergic 
signaling via irreversible inhibition of AChE should result in an anti-inflammatory effect 
(Pavlov et al. 2003). Nevertheless, these data are in general agreement with prior findings 
for sarin in a rat exposure model showing neuroinflammatory gene expression in multiple 
brain regions (Spradling et al. 2011). Increases in mRNA expression of inflammatory 
markers often are attributed to activation of microglia in response to exposure to sickness 
behavior inducing compounds (e.g., LPS or poly I:C Buttini et al. 1996; Cunningham et al. 
2007). Nevertheless, prior studies have reported that induction of inflammatory mediators by 
nerve agent (e.g., soman) may occur via neuronal rather than microglial or astrocyte 
activation (Angoa-Pérez et al. 2010). Regardless of the cell types involved in the 
neuroinflammatory responses we observed to DFP, it is tempting to assume that these 
effects are related to inhibition of AChE, a primary action of DFP. However, our findings 
may instead reflect organ-ophosphorylation of other targets yet to be identified (e.g., see 
O’Callaghan 2003). AChE actions alone cannot account for the proinflammatory effects of 
DFP, because inhibition of AChE by PB was not proinflammatory (see also Revitsky et al. 
2015).
A variety of physiological stressors were present during the GW and such stressors in 
combination with other GW exposures have been postulated to contribute to the 
development of GWI (Friedman et al. 1996; Sapolsky 1998). Moreover, physiological stress 
in the form of exercise can serve as a proinflammatory immune dysregulator (e.g., early and 
excessive activation of IL-1α, IL-10, and IL-4) in ill veterans with associated adverse 
outcomes (e.g., increases in tender points, altered brain activation during memory recall 
tasks) (Cook et al. 2010; Broderick et al. 2013; Rayhan et al. 2013). When we used 
exogenous CORT as a stressor mimic prior to DFP, it was remarkably proinflammatory, 
causing a large increase in the DFP-induced expression of cytokines/chemokines brain wide. 
While it seems paradoxical that the classic anti-inflammatory stress hormone CORT can 
exacerbate neuroinflammation, such an effect has strong precedent. A number of papers 
demonstrate that prior treatment with CORT greatly exacerbates the neuroinflammatory 
effects of lipopolysaccharide (LPS) given systemically (Hains et al. 2011; Loram et al. 
2011; Frank et al. 2014). In addition, we have shown that CORT given prior to a neurotoxic 
exposure to methamphetamine can enhance the neuroinflammatory and neurotoxic response 
to this drug (Kelly et al. 2012). Thus, at least when given prior to an inflammogen such as 
LPS or DFP or specific neurotoxicants that cause neuroinflammation (e.g., 
methamphetamine) (Kelly et al. 2012; O’Callaghan et al. 2014), CORT can exacerbate 
neuroinflammation. The basis for this CORT ‘priming’ response has not been delineated, 
and CORT does not necessarily generalize as a priming agent associated with other 
compounds that result in neuroinflammation. For example, while enhancing the 
neuroinflammation and neurotoxic effects of the dopaminergic neurotoxicant 
methamphetamine, CORT does not affect the neuroinflammation and neurotoxicity of 
another dopaminergic neurotoxicant, MPTP (O’Callaghan and Miller 2010). Regardless of 
the mechanism(s) underlying the propensity of prior CORT administration to exacerbate 
neuroinflammation, the CORT ‘priming’ of the DFP-related neuroinflammation is consistent 
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with prior data obtained in animals for other agents and is also consistent with sickness 
symptoms observed chronically in GWI.
Among the many agents and conditions encountered in the GW, two were widely self-
administered: PB pills to counteract any nerve agent exposure and DEET to ward off insects 
(RAC Reports 2008, 2014). We examined the effects of both of these compounds given 
repeatedly with and without CORT to mimic their ongoing usage in theater in the presence 
or absence of physiological stressors, and prior to DFP, to replicate a possible exposure to 
the nerve agent sarin. While epidemiological studies have implicated PB in GW etiology 
and symptoms (Schumm et al. 2002; Sullivan et al. 2003; Golomb 2008; Steele et al. 2012, 
2015), we found little effect of this reversible AChE inhibitor and the insect repellant DEET 
on neuroinflammation. Indeed, PB/DEET appeared to somewhat diminish the 
neuroinflammatory responses to DFP, an action consistent with the utility of prior treatment 
with reversible AChE inhibitors to antagonize effects of irreversible AChE inhibitor nerve 
agents such as sarin and DFP. The combination of PB/DEET with CORT pre-treatments 
failed to enhance the CORT-primed neuroinflammatory effects of DFP and negated the PB/
DEET-induced amelioration of DFP-induced neuroinflammation. These data argue that PB/
DEET exposure are not major contributors to neuroinflammation caused by DFP, and serve 
to indicate that irreversible inhibition of AChE is involved in augmented neuroinflammation 
in the CNS. Together, these observations implicate non-AChE substrates of irreversible 
organophosphorylation as a basis of agent-related neuroinflammation.
Neuroinflammation can result from neurotoxicant-induced damage (O’Callaghan et al. 
2008, 2014; Kelly et al. 2012), but also can occur in the absence of damage (O’Callaghan et 
al. 2014). To determine if the neuroinflammatory effects we observed were related to 
underlying neural damage, we used sensitive indicators (FD Neurosilver™ and Fluoro-Jade 
B staining) to assess neurodegeneration; astroglial (GFAP), and microglial (Iba1) activation 
markers were utilized to assess glial reactivity associated with possible neural damage. Our 
results showing the lack of remarkable changes in indices of neuronal damage as well as 
astrogliosis and microglial activation suggest that DFP, with and without prior treatment 
with CORT and/or PB/DEET, produced enhanced neuroinflammation in the absence of 
underlying damage. These findings stand in stark contrast to neuronal and glial responses we 
have seen following administration of a variety of known neurotoxicants (for reference 
images, see: Brock and O’Callaghan 1987; Balaban et al. 1988; Benkovic et al. 2004; Kelly 
et al. 2012; Little et al. 2002, 2012). Thus, the data from this study suggest that a brain-wide 
and perhaps persistent neuroinflammation can occur in the absence of underlying neural 
damage, as assessed by multiple sensitive markers of neuronal damage and glial activation. 
As these assessments were made soon after the dosing regimens were employed, it is 
nevertheless possible that neurodegeneration could emerge over days or weeks post-
exposure that would not be evident in our analysis (e.g., see Abdullah et al. 2011; Ojo et al. 
2014).
A main goal of developing an animal model of GWI was to provide a means to assess 
potential therapies. Because neuroinflammation was a central feature of the effects of DFP 
with and without prior CORT, we attempted to suppress these effects with an anti-
inflammatory compound. Previously, we showed suppression of neurotoxicant-induced 
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neuroinflammation by pre-treatment with MINO (Sriram et al. 2006); therefore, we used 
this non-traditional anti-inflammatory to attempt suppression of the neuroinflammation 
observed in our GWI animal model. In general, we observed a partial inhibition of the 
expression of several proinflammatory mediators, especially in HIP, by pre-treating with 
MINO along with CORT prior to DFP. These data suggest that downstream effectors of the 
cytokines and chemokines targeted by MINO, for example, NF-κB and related transcription 
factors, are amenable to pharmacological intervention in our GWI animal model, a view 
consistent with past findings showing suppression of the phosphorylation of IkBα and NF-
κB by MINO following exposure to inflammatory agents (Nikodemova et al. 2006; 
Bernardino et al. 2009; Tai et al. 2013). We administered MINO as a pre-treatment in this 
study to determine if it would suppress the development of neuroinflammation as it had in 
prior neurotoxicant exposure studies (Sriram et al. 2006). In future studies, we will 
administer MINO as a post-treatment to DFP and CORT+DFP to determine if 
neuroinflammation can be suppressed after it has fully developed, as may be the case for 
most ill GW veterans. As an already FDA-approved pharmacotherapeutic, MINO may prove 
of use in suppressing neuroinflammation not only in our animal model, but also in ill 
veterans.
Among the advantages of animal models of GWI are (i) they permit direct examination of 
tissue (especially brain), (ii) they allow for evaluation of persistent molecular, cellular, and 
functional effects associated with individual and combined exposures/conditions 
encountered in the GW, and (iii) they can be used to test specific hypotheses and evaluate 
potential therapeutic interventions. Because multiple classes of chemical exposures are 
implicated in GWI, and because non-chemical stressors also may have played a role in 
development of GWI symptoms, we evaluated several of these variables in our mouse 
model. Other investigators have also utilized rodents to develop models of GWI and have 
shown persistent behavioral and neurochemical changes following GWI-relevant exposures 
(Amourette et al. 2009; Barbier et al. 2009; Lamproglou et al. 2009; Abdullah et al. 2012; 
Parihar et al. 2013); these include evidence of delayed damage emerging months after 
exposures (Abdullah et al. 2012; Fiona Crawford, personal communication). The evidence 
obtained in our mouse model presented here primarily implicates nerve agent exposure, 
combined with high physiological levels of stress hormone, to produce a brain-wide 
neuroinflammatory response consistent with the molecular basis of sickness behavior, that 
is, symptoms exhibited by ill GW veterans. Data will be presented in a subsequent 
manuscript indicating that the mouse GWI phenotype presented here can persist in time to 
the equivalent of 20 years in man. The efficacy of MINO in suppressing expression of 
proinflammatory cytokines in our model provides a promising lead for future experiments in 
animals designed to determine if anti-inflammatory therapies can be used successfully to 
treat neuroinflammation long after it develops, as may be the case in GWI. A positive 
outcome of such studies should be of translational value for implementing therapeutic 
interventions in ill GW veterans. In summary, our findings are suggestive of a possible 
critical interaction between physiological stressors of the GW theater and agent exposure(s) 
unique to this war; exposures in which the CNS is primed to amplify future exposures to 
pathogens, injury or toxicity and result in symptoms of sickness behavior characteristic of 
GWI.
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Dosing paradigm. Time-line for administration of diisopropyl fluorophosphate (DFP) (4 
mg/kg, i.p.) with and without prior administration of corticosterone (CORT) (200 mg/L in 
drinking water) and/or pyridostigmine bromide (PB) (2 mg/kg/day, s.c.) and N,N-diethyl-
meta-toluamide (DEET) (30 mg/kg/day, s.c.) (a), or minocycline (MINO) (100 mg/kg/day, 
s.c.) (b).
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Diisopropyl fluorophosphate (DFP) causes neuroinflammation in multiple brain regions. 
Mice were administered DFP (4 mg/kg, i.p.) with saline (0.9%) as control and were killed at 
6 h post dosing. Total RNA was prepared from frontal cortex (FC), hippocampus (HIP), 
striatum (STR), hypothalamus (HYPO), olfactory bulbs (OB), and cerebellum (CB) and for 
q-PCR analysis of tumor necrosis factor-alpha (TNF-α), IL6, chemokine (C-C motif) ligand 
2 (CCL2), IL-1β, leukemia inhibitory factor (LIF), and oncostatin M (OSM). All data points 
represent mean ± SEM, n = 5. Group differences between saline and DFP exposed mice 
were measured by Student’s t-test, and statistical significant was measured at p < 0.05 is 
denoted by * as compared to saline controls.
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Diisopropyl fluorophosphate (DFP) causes a time-dependent neuroinflammation in frontal 
cortex (FC) and hippocampus (HIP). Mice were administered DFP (4 mg/kg, i.p.) with 
saline (0.9%) as control and were killed at 2–12 h post dosing. Total RNA was prepared 
from FC or HIP for q-PCR analysis of tumor necrosis factor-alpha (TNF-α), IL6, chemokine 
(C-C motif) ligand 2 (CCL2), IL-1β, leukemia inhibitory factor (LIF), and oncostatin M 
(OSM). All data points represent mean ± SEM, n = 5. Differences between mice in saline 
and DFP groups and time course data were analyzed using a two-way ANOVA, with 
Fisher’s LSD Method of post hoc analysis, p < 0.05 is denoted by *as compared to saline 
control, #as compared to the 6 h time point within the appropriate brain region, and §as 
compared to the 2 h time point within the appropriate brain region. Symbols used to mark 
differences observed in the FC alone are in red, differences in HIP alone are in blue, and 
differences in both groups are marked in green.
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Pre-treatment with corticosterone (CORT) enhances diisopropyl fluorophosphate (DFP)-
induced neuroinflammation in multiple brain regions. Mice were administered CORT (200 
mg/L) in the drinking water for 1 week prior to administration of DFP (4 mg/kg, i.p.) with 
saline (0.9%) as control and were killed at 6 h post dosing. Total RNA was prepared from 
frontal cortex (FC), hippocampus (HIP), striatum (STR), hypothalamus (HYPO), olfactory 
bulbs (OB), and cerebellum (CB) for q-PCR analysis of tumor necrosis factor-alpha (TNF-
α), IL6, chemokine (C-C motif) ligand 2 (CCL2), IL-1β, leukemia inhibitory factor (LIF), 
and oncostatin M (OSM). All data points represent mean ± SEM, n = 5. Group differences 
between mice exposed to DFP and mice exposed to CORT+DFP treatments was measured 
using a Student’s t-tests, and statistical significant was measured at p < 0.05 is denoted by * 
as compared to DFP alone.
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Pre-treatment with corticosterone (CORT) enhances diisopropyl fluorophosphate (DFP)-
induced neuroinflammation in a time-dependent manner in frontal cortex (FC) and 
hippocampus (HIP). Mice were administered CORT (200 mg/L) in the drinking water for 1 
week prior to administration of DFP (4 mg/kg, i.p.) with saline (0.9%) as control and were 
killed at 2, 6, and 12 h post dosing. Total RNA was prepared from FC or HIP for q-PCR 
analysis of tumor necrosis factor-alpha (TNF-α), IL6, chemokine (C-C motif) ligand 2 
(CCL2), IL-1β, leukemia inhibitory factor (LIF), and oncostatin M (OSM). All data points 
represent mean ± SEM, n = 5. Differences between mice in DFP and CORT +DFP groups 
and time course data were analyzed using a two-way ANOVA, with Fisher’s LSD Method of 
post hoc analysis, p < 0.05 is denoted by *as compared to DFP, #as compared to the 6 h time 
point and §as compared to the 2 h time point. Symbols used to mark differences observed in 
the DFP alone are in red, differences in CORT + DFP alone are in blue, and differences in 
both groups are marked in green.
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Pyridostigmine bromide (PB)/N,N-diethyl-meta-toluamide (DEET) pre-treatment can reduce 
diisopropyl fluorophosphate (DFP)-induced neuroinflammation. Mice were administered PB 
(4 mg/kg/day, s.c.) and DEET (30 mg/kg/day, s.c) prior to administration of DFP (4 mg/kg, 
i.p). See Fig. 1 for dosing timeline. Saline (0.9%) was used as control and mice were killed 
at 6 h post dosing. Total RNA was prepared from frontal cortex (FC), hippocampus (HIP) 
and striatum (STR) for q-PCR analysis of tumor necrosis factor-alpha (TNF-α), IL6, 
chemokine (C-C motif) ligand 2 (CCL2), IL-1β, leukemia inhibitory factor (LIF), and 
oncostatin M (OSM). All data points represent mean ± SEM, n = 5. The treatment effect of 
PB/DEET on mice exposed to DFP was analyzed using a two-way ANOVA, with Fisher’s LSD 
Method of post hoc analysis, p < 0.05 is denoted by *as compared to control, #as compared 
to DFP.
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Corticosterone (CORT) exposure negates the amelioration of diisopropyl fluorophosphate 
(DFP)-induced neuroinflammation by pyridostigmine bromide (PB)/N,N-diethyl-meta-
toluamide (DEET). Mice were administered PB (4 mg/kg/day, s.c.) and DEET (30 mg/kg/
day, s.c), with and without co-administration of CORT (200 mg/L) in drinking water prior to 
administration of DFP (4 mg/kg, i.p). See Fig. 1 for dosing timeline. Saline (0.9%) was used 
as control and mice were killed at 6 h post dosing. Total RNA was prepared from frontal 
cortex (FC), hippocampus (HIP), and striatum (STR) for q-PCR analysis of tumor necrosis 
factor-alpha (TNF-α), IL6, chemokine (C-C motif) ligand 2 (CCL2), IL-1β, leukemia 
inhibitory factor (LIF), and oncostatin M (OSM). All data points represent mean ± SEM, n = 
5. Statistical significance was measured by one-way ANOVA with Fisher’s LSD Method of 
post hoc analysis, p < 0.05 is denoted by *as compared to DFP, #as compared to CORT
+DFP.
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Diisopropyl fluorophosphate (DFP) with and without prior pyridostigmine bromide (PB)/
N,N-diethyl-meta-toluamide (DEET)+corticosterone (CORT) did not cause remarkable 
neurodegeneration or gliosis. Mice were administered PB (4 mg/kg/day, s.c.) and DEET (30 
mg/kg/day, s.c), with and without co-administration of CORT (200 mg/L) in drinking water 
prior to administration of DFP (4 mg/kg, i.p). See Fig. 1 for dosing timeline. Saline (0.9%) 
was used as control and mice were killed at 24-h post dosing. Neurodegeneration as indexed 
by silver disintegration staining (a) or Fluoro-Jade B staining (b) did not reveal evidence of 
neuronal damage in the hippocampus (HIP). Astroglial staining with glial fibrillary acidic 
protein (GFAP) (c) did not show evidence of astrogliosis; microglial staining with ionized 
calcium-binding adapter molecule 1 (Iba1) (d) did not reveal microglial activation in the 
HIP. Scale bars = 100 μm (Silver) and 200 μm (Fluoro-Jade B, GFAP, and Iba1).
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Diisopropyl fluorophosphate (DFP) with and without prior pyridostigmine bromide (PB)/
N,N-diethyl-meta-toluamide (DEET)+ corticosterone (CORT) did not increases glial 
fibrillary acidic protein (GFAP) in multiple brain regions. Mice were administered PB (4 
mg/kg/day, s.c.) and DEET (30 mg/kg/day, s.c), with and without co-administration of 
CORT (200 mg/L) in drinking water prior to administration of DFP (4 mg/kg, i.p). See Fig. 
1 for dosing timeline. Saline (0.9%) was used as control and mice were killed at 72-h post 
dosing. Immunoassay of GFAP levels in frontal cortex (FC), hippocampus (HIP) or striatum 
(STR), as a quantitative index of astrogliosis did not reveal any significant effects as a 
function of any of the treatments. All data points represent mean + SEM, n = 5. Statistical 
significance was measured by one-way ANOVA with Fisher’s LSD Method of post hoc 
analysis, p < 0.05 is denoted by *as compared to control.
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Pre-treatment with minocycline (MINO) partially suppresses neuroinflammation induced by 
corticosterone (CORT)+diisopropyl fluorophosphate (DFP) in frontal cortex (FC) and 
hippocampus (HIP). Mice were pre-treated with CORT (200 mg/L in drinking water) with 
and without co-administration of MINO (100 mg/kg/day, s.c.) prior to administration of 
DFP (4 mg/kg, i.p). See Fig. 1 for dosing timeline. Saline (0.9%) was used as control and 
mice were killed at 6-h post DFP dosing. Total RNA was prepared from FC and HIP for q-
PCR analysis of tumor necrosis factor-alpha (TNF-α), IL6, chemokine (C-C motif) ligand 2 
(CCL2), IL-1β, leukemia inhibitory factor (LIF), and oncostatin M (OSM). All data points 
represent mean + SEM, n = 5. Statistical significance was measured by one-way ANOVA 
with Fisher’s LSD Method of post hoc analysis, p < 0.05 is denoted by *as compared to 
control and #as compared to CORT+DFP. Previously, we have shown that MINO alone does 
not affect cytokine or chemokine expression using the regimen employed in this study 
(Sriram et al. 2006; O’Callaghan et al. 2008).
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